SPP1 and COVID-19: More recently, in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, it was found that OPN serum levels were higher in patients with severe coronavirus disease 2019 (COVID-19) when compared with patients with a mild disease presentation [23].